Back to Search Start Over

131I-labeled lipiodol-induced interstitial pneumonia.

Authors :
Jouneau, S.
Polard, E.
Vauléon, E.
Caulet-Maugendre, S.
Volatron, A.C.
Delaval, P.
Source :
Respiratory Medicine CME; Mar2011, Vol. 4 Issue 1, p41-43, 3p
Publication Year :
2011

Abstract

Abstract: Drug-induced interstitial pneumonia is a severe disease that has been reportedly caused by more than 100 compounds, the most common being amiodarone, methotrexate and bleomycin. We report a case of fatal acute interstitial pneumonia occurring after a second injection of <superscript>131</superscript>I-labeled lipiodol for hepatocellular carcinoma treatment. Infectious pneumonia was ruled out and lung biopsy revealed a pattern of usual interstitial pneumonia. Despite early initiation of systemic corticosteroids and additionally, antioxidant medications, the patient’s condition gradually worsened and he died 24 days after admission. <superscript>131</superscript>I-labeled lipiodol-induced interstitial pneumonia is probably frequently undiagnosed. A better knowledge of this disease would help to estimate its true incidence and may impact on the perceived risk/benefit ratio for its treatment. Moreover, this may have consequences on the prescription of <superscript>131</superscript>I-labeled lipiodol. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
17550017
Volume :
4
Issue :
1
Database :
Supplemental Index
Journal :
Respiratory Medicine CME
Publication Type :
Academic Journal
Accession number :
60563583
Full Text :
https://doi.org/10.1016/j.rmedc.2010.05.001